| Chemical Properties | White Solid |
| Uses | An labelled angiotensin II receptor antagonist. Used as an anti-hypertensive |
| Uses | An angiotensin II receptor antagonist. Used as an anti-hypertensive |
| Uses | Angiotensin II inhibitor, antihypertensive |
| Uses | An angiotensin II (AT1) receptor antagonist |
| Uses | Olmesartan Acid (Olmesartan EP Impurity A) is an angiotensin II receptor antagonist. Used as an anti-hypertensive. |
| General Description | Olmesartan medoxomil, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl-5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (Benicar, Olmetec) uses the tetrazolering system as its acidic system, which participates inreceptor binding.When administered to a patient, the drugis rapidly and completely bioactivated by ester hydrolysis ofthe medoxomil during absorption from the gastrointestinaltract. Once the prodrug is converted to the active form, virtuallyno further metabolism occurs. In September 2007, theFood and Drug Administration (FDA) approved its use as acombination product with the calcium channel blocker amlodipinefor the management of hypertension. This combinationproduct is sold under the tradename of Azor. |
| Biochem/physiol Actions | Olmesartan possesses anti-inflammatory and anti-oxidative stress properties. It protects neuronal cells against oligomerized amyloid β (Aβ)-induced cellular senescence. |
日本语
한국어
Français
Deutsch
España
Türkiye